C.D.C. Panel to Meet Next Friday on J.&J. Vaccine Pause
The federal governments call for a pause on using Johnson & Johnsons Covid-19 vaccine could last at least another week, further complicating efforts by federal and state health officials to reschedule appointments, and reassure jittery Americans that the vaccine is safe and effective.
The Centers for Disease Control and Preventions independent vaccine advisory panel, known as the Advisory Committee on Immunization Practices, or ACIP, has been scheduled to meet for a second time since shots were halted, next Friday, to discuss safety data related to a small number of blood-clotting cases in Johnson & Johnson vaccine recipients. It is unclear whether the vaccine was responsible for the clots.
The public, six-hour meeting could conclude with a vote, for example, to recommend to continue the pause, to modify the F.D.A.s authorization of the single-dose vaccine or to rescind the pause altogether. The federal government could then act quickly to follow the guidance.
We recognize the critical importance of moving quickly. Thats why we will have two unscheduled ACIP meetings in a 10-day period, Dr. Rochelle P. Walensky, the C.D.C. director, said at a White House news conference Friday.
https://www.msn.com/en-us/news/us/cdc-panel-to-meet-next-friday-on-jandj-vaccine-pause/ar-BB1fJjim